PRI Headers (2)

 

  • Mind the Brain: Dr. Tracy Bale on Epigenetic Research of Stress Across the Lifespan

    Jun 7, 2022
    This week on Mind the Brain, Dr. Epperson is joined by Dr. Tracy Bale, Professor of Pharmacology at the University of Maryland School of Medicine and Director of the Center for Epigenetic Research in Child Health and Brain Development. Dr. Bale and Dr. Epperson discuss early childhood stress, and the benefits of using mouse models to study stress responses neuroscientific and psychiatric research.
    Full story
  • Mind the Brain: Dr. L. Helen Coons on Infertility and Mental Health

    May 24, 2022
    This week on Mind the Brain, Dr. Epperson is joined by Dr. Helen L. Coons, a board-certified clinical health psychologist. Dr. Coons is an Associate Professor in the Department of Psychiatry at CU Anschutz and the Clinical Director for the Women's Behavioral Health and Wellness Service Line. For the past two decades, she has collaborated with healthcare providers to treat women and couples coping with infertility and other health and mental health concerns. On this episode, Dr. Epperson shares a riveting conversation with Dr. Coons about her work with patients experiencing fertility challenges, and discuss the impact of infertility and fertility treatment on women’s health and emotional well-being.
    Full story
  • Mind the Brain: Dr. Kent Hutchison on Cannabidiol (or CBD) Research

    May 10, 2022
    On this episode of Mind the Brain, Dr. Epperson is joined by Dr. Kent Hutchison to discuss Cannabidiol (or CBD) research. Dr. Hutchison is a professor at the CU Anschutz Department of Psychiatry, and also works as an adjunct professor at the University of Colorado Boulder in their Psychology and Neuroscience department. He is affiliated with the CU-Boulder Institute of Cognitive Science, where he conducts research on combining neuroimaging, epigenetic, pharmacological, and clinical perspectives to develop more effective addiction intervention and prevention strategies. Most recently, he is conducting alcohol and cannabis research, neuroimaging, and blood-based biomarkers under one conceptual framework that emphasizes the cannabinoids, endocannabinoids, inflammation, and the brain. On this episode, Dr. Epperson and Dr. Hutchison discuss CBD research in Psychiatry.
    Full story
  • Mind the Brain: Lily Luo and Emmaly Perks on the PURPLE Program

    Apr 19, 2022
    This week on Mind the Brain, Dr. Epperson is joined by Emmaly Perks and Lily Luo – the directors behind the CU Psychiatry PURPLE program. PURPLE stands for Psychiatry Undergraduate Research Program and Learning Experience, and is designed to introduce young people to the field of mental health by encouraging participation in supervised research activities. On this episode, Dr. Epperson and her guests talk about this program and how it has opened a pathway to careers in medicine for many students.
    Full story
  • Mind the Brain: Dr. Winnie Hunter on Sexual Health

    Mar 15, 2022
    On this new episode of Mind the Brain, Dr. Neill Epperson is joined by Dr. Winnie Hunter. Dr. Hunter is a Senior Instructor and Clinical Psychologist in the Department of Psychiatry at the CU Anschutz Medical Campus, and the lead therapist for the Women's Sexual Health Consultation Service within the CU Department of Obstetrics and Gynecology. On this episode, Dr. Epperson and Dr. Hunter discuss all things sexual health: what is it? How do we get it? How do we know when we have it? How do we maintain it?
    Full story
  • Mind the Brain: Dr. Thida Thant and Dr. Rose Mauch on Pandemic Brain and Post-COVID Brain

    Jun 29, 2021
    This week on Mind the Brain, Dr. Neill Epperson is joined by Drs. Thida Thant and Rose Mauch. Dr. Thant is the director of the University of Colorado Consultation-Liaison Psychiatry Service and the Psychiatric Consultation for the Medically Complex clinic. She has expertise in the evaluation and management of psychiatric symptoms in the context of medical and neurological illness. Dr. Mauch is currently a 3rd year psychiatry resident at the University of Colorado, and is interested in how long-term effects of early childhood trauma on psychiatric and medical illness. Together, they discuss a phenomenon many of us have experienced – a phenomenon called ‘pandemic brain.’
    Full story
 

 

 

Why We Created Mind the Brain

Resilience — what is it and how to boost it — has become a recent focus of numerous medical talk shows, blogs, books and electronic apps. Surveys to calculate one’s resilience quotient have become popular. Of course, facing the morbidity, mortality, social isolation and economic uncertainty that characterizes the COVID-19 pandemic, we crave concrete reassurance that we and our loved ones are going to be okay. We will weather this storm. We will bounce back, as one of my colleagues texted me earlier today, “Bigger, badder, stronger.”

Indeed, the majority of us will demonstrate resilience. We will return to our workplaces, schools, houses of worship, favorite restaurants, and mountain trails with no appreciable adverse health effects from the pandemic.

However, this is not the case for roughly one million Coloradans who will suffer from mental health concerns this year alone. Add the adverse psychological and biological effects of chronic, pervasive and persistent stress to the baseline prevalence of any mental disorder (19%) or serious mental illness (5%) and we should expect — and prepare for — a surge in suicides, depression, post-traumatic stress disorders, anxiety disorders and problems with alcohol and drug use.

 

Mental Illness: The Second Surge?

While we have had other infectious disease scares and disasters in the U.S., we have not experienced a pandemic of this scope for more than a century. This type of disaster is unprecedented in our current society. We are psychologically inexperienced.

However, it is time that we go beyond focusing on emotional supports and discussing resilience, coping strategies, sleep hygiene or exercise routines. While these are all admittedly important to one’s well-being, we must launch a frank dialogue about psychiatric disorders as the “second surge” of this pandemic.

Over the next several weeks, we will begin an open and honest discussion of what we can expect, from a psychiatric point of view, over the coming months. We will publish conversations with experts in the assessment and treatment of depression, anxiety, PTSD and other stress reactions, as well as problems with substance use and abuse. These are exceptionally common medical problems in our society and, like COVID-19, are not exclusive to any particular socioeconomic class, race, ethnic or age group, sex or gender.

Our goal is to promote recognition that mental illness can strike any of us during and after this pandemic. It is important to recognize the signs and symptoms in ourselves and others. Mental health care is available through multiple avenues such as one’s primary care provider, the Department of Psychiatry and the Johnson Depression Center. There is no shame in reaching out for help. Suffering from depression or PTSD does not mean that one is not resilient. Resilience is complex and multifaceted. Appropriate and timely treatment can aid a person’s innate resilience and return him or her to health.

We hope you will take a few minutes to read and discuss these articles. The more frequently we speak the words “depression, PTSD, panic, suicide” the less stigmatized they become. I am optimistic that one day we will feel as comfortable seeking treatment for psychiatric and substance use concerns as we are for any other common medical condition. The majority of psychiatric disorders are episodic and highly responsive to treatment. Let’s all do what we can to prevent this second surge from becoming the chronic medical condition that will be the legacy of the COVID-19 pandemic.

 

Screen Shot 2020-12-09 at 8.40.27 AM

C. Neill Epperson, M.D.
Robert Freedman Endowed Professor and Chair 
Department of Psychiatry 

C. Neill Epperson, MD


Chair, Department of Psychiatry 


Host, Mind the Brain